Advertisement
Document › Details
Bruker Corporation. (7/17/19). "Press Release: Bruker Comments on Block Trade Transaction". Billerica, MA.
Organisation | Bruker Corporation (Nasdaq: BRKR) | |
Group | Bruker (Group) | |
Product | analytical instrument | |
Product 2 | diagnostics (medical/biological) | |
Person | Laukien, Jörg C. (Bruker –201811 Board Member RETIRED 11/18) | |
Person 2 | Laukien, Frank H. (Bruker 201204 President + CEO) | |
Bruker Corporation (Nasdaq: BRKR) has been advised that former board member, Mr. Joerg C. Laukien, has authorized a block sale of Bruker shares as part of his retirement planning and portfolio diversification. Joerg Laukien retired from the Bruker board of directors effective November 5, 2018. He is the brother of Bruker's President and CEO Frank H. Laukien, who is not selling any shares in this transaction.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.
Contact :
Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
E: miroslava.minkova@bruker.com
Record changed: 2023-06-05 |
Advertisement
More documents for Bruker (Group)
- [1] Biognosys AG. (4/4/24). "Press Release: Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research". Zürich & Fremont, CA....
- [2] Bruker Corporation. (1/25/24). "Press Release: Bruker Announces Agreement to Acquire Chemspeed". Basel....
- [3] Bruker Corporation. (1/23/24). "Press Release: Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts". Zürich & Newton, MA....
- [4] Bruker Corporation. (1/3/24). "Press Release: Bruker Acquires Electron Microscopy Company Nion". Billerica, MA....
- [5] Bruker Corporation. (12/26/23). "Form 8-K. Current Report [Acquisition of Elitech Group by Bruker for €870m from PAI Partners] CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest ev...
- [6] Bruker Corporation. (10/4/23). "Press Release: Bruker Announces Majority Investment in MIRO Analytical AG, an Innovator in Compact, Highest-Precision QCL-Based Multi-Gas Analyzers (MGA)". Zürich....
- [7] Bruker Corporation. (10/3/23). "Press Release: Bruker Completes Acquisition of PhenomeX". Billerica, MA....
- [8] Bruker Corporation. (9/18/23). "Press Release: Bruker Introduces Novel 4D-Proteomics timsTOF Capabilities". Busan....
- [9] Bruker Corporation. (8/17/23). "Press Release: Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction". Billerica, MA & Emeryville, CA....
- [10] Bruker Corporation. (6/2/23). "Press Release: Bruker Corporation to Present at Jefferies 2023 Healthcare Conference". Billerica, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top